Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

A clinical case of a patient with newly diagnosed type 2 diabetes mellitus (DM2) is presented. The patient with a diagnosis of “impaired glucose tolerance” was not seen by an endocrinologist, did not follow a diet, independently discontinued the prescribed metformin, and did not control her glycemic level. She consulted an endocrinologist when started planning her pregnancy. The patient was diagnosed with type 2 diabetes mellitus, and combination glucose-lowering therapy was recommended. Next, the selection of therapy was assessed, the reliable long-term compensation of diabetes was achieved, and the long-awaited pregnancy occurred.

Conclusion. Therapy with gosogliptin has proven its effectiveness and safety in early treatment using rational combinations of drugs with a high safety profile.

全文:

受限制的访问

作者简介

J. Markina

D.O. Ott Research Institute of Obstetrics and Gynecology

编辑信件的主要联系方式.
Email: juliamarkinaendo@gmail.com

Endocrinologist

俄罗斯联邦, St. Petersburg

参考

  1. Дедов И.И., Шестакова М.В., Майоров А.Ю. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 10-й выпуск. Сахарный диабет. 2021;24(1S.):1–148. doi: 10.14341/DM12802.
  2. Sun H., Saeedi P., Karuranga S., et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diab Res Clin Pract. 2022;183(Art. ID):109119. doi: 10.1016/j.diabres.2021.109119.
  3. Галстян К.О., Недосугова Л.В., Петунина Н.А. и др. Первый отечественный ингибитор ДПП-4 госоглиптин в сравнении с вилдаглиптином при лечении пациентов с сахарным диабетом 2 типа. Сахарный диабет. 2016;19(1):89–96. [Galstyan K.O., Nedosugova L.V., Petunina N.A., Trakhtenberg J.A., Vostokova N.V., Karavaeva O.V., Chasovskaya T.E. First Russian DPP-4 inhibitor Gosogliptin comparing to Vildagliptin in type 2 diabetes mellitus patients. Diabetes mellitus. 2016;19(1):89-96. (In Russ.)]. Doi: 10.14341/ DM7233.
  4. Knowler W.C., Barret-Connor E., Fowler S.E., et al. Reduction in the Incidence of type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med. 2002;346(6):393–403. doi: 10.1056/NEJMoa012512.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2024
##common.cookie##